Degrees Pharmaceuticals, Inc. CONFIDENTIAL All rights reserved. October 2025 1 - 8 - 26 Webinar Disclaimer and Forward - looking Statements 2024 60 Degrees Pharmaceuticals, Inc. CONFIDENTIAL All rights reserved. DISCLAIM
Thursday, January 8, 2026 1 min read
Key Takeaway: Commercial Pilot for Malaria Indication Addresses Barriers to Use Increase Awareness and Differentiate ARAKODA D ifferentiate ARAKODA from the generic competition with a clear and compelling value story through different channels Drive ARAKODA Trial & Usage Additional Inside Sale
Full Press Release Details
Commercial Pilot for Malaria Indication Addresses Barriers to Use Increase Awareness and Differentiate ARAKODA D ifferentiate ARAKODA from the generic competition with a clear and compelling value story through different channels Drive ARAKODA Trial & Usage Additional Inside Sales Representatives - Encourage HCPS to prescribe ARAKODA for appropriate patients based on product attributes Facilitate Access & Affordability Manage high OOP through GoodRx point of sale discount